ClariVest Asset Management LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$423,000
-5.4%
16,430
-4.0%
0.01%
-6.7%
Q2 2021$447,000
+22.8%
17,108
+65.7%
0.02%
+15.4%
Q1 2021$364,000
+67.0%
10,324
+19.7%
0.01%
+85.7%
Q4 2020$218,000
-71.6%
8,623
-57.6%
0.01%
-72.0%
Q3 2020$768,000
-15.9%
20,355
-4.5%
0.02%0.0%
Q2 2020$913,00021,3070.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders